These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 549184)

  • 1. Surface antigens as virulence factors in infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Polk BF; Bartlett JG
    Rev Infect Dis; 1979; 1(2):278-90. PubMed ID: 549184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model.
    Kasper DL; Onderdonk AB
    Scand J Infect Dis Suppl; 1982; 31():28-33. PubMed ID: 6954635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains.
    Onderdonk AB; Kasper DL; Cisneros RL; Bartlett JG
    J Infect Dis; 1977 Jul; 136(1):82-9. PubMed ID: 886206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenicity of Bacteroides fragilis group in rat intra-abdominal abscesses.
    Jotwani R; Gupta U; Watanabe K; Ueno K
    Microbiol Immunol; 1992; 36(10):1041-9. PubMed ID: 1479960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
    Lindberg AA; Weintraub A
    Scand J Infect Dis Suppl; 1985; 46():27-32. PubMed ID: 3865350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Crabb J; Bartlett JG
    J Infect Dis; 1979 Nov; 140(5):724-31. PubMed ID: 528789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition.
    Kasper DL
    J Infect Dis; 1976 Jan; 133(1):79-87. PubMed ID: 1451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis.
    Onderdonk AB; Shapiro ME; Finberg RW; Zaleznik DF; Kasper DL
    Rev Infect Dis; 1984; 6 Suppl 1():S91-5. PubMed ID: 6372042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative determination of the antibody response to the capsular polysaccharide of Bacteroides fragilis in an animal model of intraabdominal abscess formation.
    Kasper DL; Onderdonk AB; Bartlett JG
    J Infect Dis; 1977 Dec; 136(6):789-95. PubMed ID: 336801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of subinhibitory doses of clindamycin on the virulence of Bacteroides fragilis: role of lipopolysaccharide.
    Zaleznik DF; Zhang ZL; Onderdonk AB; Kasper DL
    J Infect Dis; 1986 Jul; 154(1):40-6. PubMed ID: 3711690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal model system for studying virulence of and host response to Bacteroides fragilis.
    Onderdonk AB; Cisneros RL; Finberg R; Crabb JH; Kasper DL
    Rev Infect Dis; 1990; 12 Suppl 2():S169-77. PubMed ID: 2406869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemical characterization of surface antigens of Bacteroides melaninogenicus.
    Mansheim BJ; Onderdonk AB; Kasper DL
    Rev Infect Dis; 1979; 1(2):263-77. PubMed ID: 44922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virulence factors in Bacteroides fragilis group.
    Jotwani R; Gupta U
    Indian J Med Res; 1991 Jul; 93():232-5. PubMed ID: 1959952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model.
    Onderdonk AB; Markham RB; Zaleznik DF; Cisneros RL; Kasper DL
    J Clin Invest; 1982 Jan; 69(1):9-16. PubMed ID: 6976357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immunity to Bacteroides fragilis capsular polysaccharide.
    Shapiro ME; Onderdonk AB; Kasper DL; Finberg RW
    J Exp Med; 1982 Apr; 155(4):1188-97. PubMed ID: 6174672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to detect capsular diversity among Bacteroides fragilis isolates.
    Pantosti A; Colangeli R; Tzianabos AO; Kasper DL
    J Clin Microbiol; 1995 Oct; 33(10):2647-52. PubMed ID: 8567899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemistry of the surface carbohydrate antigens of Bacteroides fragilis and definition of a common antigen.
    Poxton IR; Brown R
    J Gen Microbiol; 1986 Sep; 132(9):2475-81. PubMed ID: 2432160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the common immunodominant antigenic determinant in the lipopolysaccharide of Bacteroides fragilis by a monoclonal antibody.
    Linko L; Weintraub A; Arstila P; Pelliniemi LJ; Viljanen MK
    Scand J Immunol; 1987 May; 25(5):469-75. PubMed ID: 2438749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological detection of Bacteroides fragilis in clinical samples.
    Patrick S; Stewart LD; Damani N; Wilson KG; Lutton DA; Larkin MJ; Poxton I; Brown R
    J Med Microbiol; 1995 Aug; 43(2):99-109. PubMed ID: 7629860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenicity of the Bacteroides fragilis group.
    Brook I
    Ann Clin Lab Sci; 1989; 19(5):360-76. PubMed ID: 2679351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.